G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes

P M O'Connor1, D K Ferris, M Pagano

  • 1Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Insights

DNA damage in lymphoma cells causes cell cycle arrest by altering cyclin-dependent kinase activity. Pentoxifylline reverses this arrest by disrupting the regulatory pathway, offering potential therapeutic insights.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Pharmacology

Background:

  • Cell cycle progression is tightly regulated by cyclin-dependent kinases (CDKs).
  • DNA damage can induce cell cycle arrest to allow for repair or apoptosis.
  • Understanding CDK regulation in response to DNA damage is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the temporal regulation of cyclin A- and B1-dependent kinases in human lymphoma cells following DNA damage.
  • To determine if CDK activity correlates with cell cycle arrest induced by nitrogen mustard (HN2).
  • To evaluate the effect of pentoxifylline on cell cycle arrest and CDK activity in HN2-treated cells.

Main Methods:

  • Human lymphoma cells were synchronized in G1/S phase.
  • Cells were treated with nitrogen mustard (HN2) to induce DNA damage.
  • Post-treatment incubation with pentoxifylline was performed.
  • Kinase activities of cyclin A- and B1-dependent complexes were assessed.
  • Cell cycle progression and protein levels were analyzed.

Main Results:

  • HN2 induced a G2 phase delay, correlating with suppressed cyclin B1/cdc2 and cyclin A/cdc2 kinase activities.
  • HN2 did not affect S phase activity of cyclin A/cdk2 or cyclin B1/cdk2 complexes.
  • G2 delay was associated with stabilized cyclin A, increased cyclin A-bound cdk2, and elevated cdk2 activity.
  • Pentoxifylline abrogated HN2-induced cell cycle arrest and restored CDK activities to control levels.

Conclusions:

  • Delayed entry into mitosis after DNA damage is linked to suppressed cyclin B1/cdc2 activity but maintained active cyclin A/cdk2 complexes.
  • Pentoxifylline disrupts the signal transduction pathway regulating CDKs in the presence of damaged DNA, thereby abrogating cell cycle arrest.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...